CTIC logo

CTI BioPharma (CTIC) Revenue

Annual Revenue

$53.95 M
NaN%

December 31, 2022

Summary

Performance

1-Year Change

-

3-Year Change

+1512.8%

5-Year Change

+114.54%

15-Year Change

+114.54%

CTIC Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$114.76 M
CTIC annual revenue is currently -52.99% lower than the consensus analysts' forecast

High & Low

All-time High

$60.08 M
CTIC annual revenue is currently -10.20% below its historical high of $60.08 million

3-Year Low

$53.95 M
CTIC annual revenue is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICprofitabilitymetrics:

Annual EPS

-$0.81
CTIC annual earnings per share is -$0.81

Annual Net Income

-$92.99 M
CTIC annual net profit is -$92.99 million

Annual Operating Profit

-$79.80 M
CTIC annual operating income is -$79.80 million

Annual Gross Profit

$50.43 M
CTIC annual gross profit is $50.43 million

Quarterly Revenue

$24.12 M
+$3.03 M+14.39%

March 31, 2023

Summary

Performance

3-Month Change

+14.39%

1-Year Change

+950.81%

3-Year Change

-

5-Year Change

+122.35%

CTIC Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$26.57 M
CTIC quarterly revenue is currently -9.24% lower than the consensus analysts' forecast

High & Low

All-time High

$39.53 M
CTIC quarterly revenue is currently -39.00% below its historical high of $39.53 million

3-Year Low

$2.29 M
CTIC quarterly revenue is currently +950.81% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$22.89 M
CTIC quarterly gross profit is $22.89 million

Quarterly Operating Profit

-$9.23 M
CTIC quarterly operating income is -$9.23 million

Quarterly Net Income

-$13.42 M
CTIC quarterly net profit is -$13.42 million

Quarterly EPS

-$0.10
CTIC quarterly earnings per share is -$0.10

TTM Revenue

$75.77 M
+$21.82 M+40.45%

March 31, 2023

Summary

Performance

3-Month Change

+40.45%

1-Year Change

+3201.48%

3-Year Change

-

5-Year Change

-

CTIC TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$90.01 M
CTIC TTM revenue is currently -15.82% lower than the consensus analysts' forecast

High & Low

All-time High

$75.77 M
CTIC TTM revenue is currently at an all-time high

3-Year Low

$2.29 M
CTIC TTM revenue is currently +3201.48% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICprofitabilitymetrics:

TTM Gross Profit

$71.31 M
CTIC TTM gross profit is $71.31 million

TTM Operating Profit

-$53.93 M
CTIC TTM operating income is -$53.93 million

TTM Net Income

-$69.24 M
CTIC TTM net profit is -$69.24 million

TTM EPS

-$0.58
CTIC TTM earnings per share is -$0.58

CTIC Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+950.8%+3201.5%
3 y3 years+1512.8%--
5 y5 years+114.5%+122.3%-

CTIC Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high-90.5%at high-97.0%
5 y5-yearat high-93.8%at high-90.5%at high-97.0%
alltimeall time-10.2%-99.9%-39.0%-100.0%at high-99.9%

CTI BioPharma Revenue History

DateAnnualQuarterlyTTM
Mar 2023
-
$24.12 M(+14.4%)
$75.77 M(+40.4%)
Dec 2022
$53.95 M(+1512.8%)
$21.08 M(+15.6%)
$53.95 M(+64.2%)
Sep 2022
-
$18.24 M(+48.0%)
$32.87 M(+124.7%)
Jun 2022
-
$12.33 M(+437.2%)
$14.62 M(+537.2%)
Mar 2022
-
$2.29 M(+0.3%)
$2.29 M(-86.9%)
Dec 2019
$3.35 M(-87.3%)
-
-
Sep 2019
-
$2.29 M(+450.2%)
$17.45 M(+9.9%)
Jun 2019
-
$416.00 K(-35.0%)
$15.89 M(-1.2%)
Mar 2019
-
$640.00 K(-95.5%)
$16.08 M(-38.8%)
Dec 2018
$26.29 M(+4.5%)
$14.11 M(+1851.3%)
$26.29 M(+107.9%)
Sep 2018
-
$723.00 K(+17.9%)
$12.64 M(-7.2%)
Jun 2018
-
$613.00 K(-94.3%)
$13.63 M(-61.3%)
Mar 2018
-
$10.85 M(+2247.6%)
$35.24 M(+40.1%)
Dec 2017
$25.15 M(-56.2%)
$462.00 K(-72.9%)
$25.15 M(-25.6%)
Sep 2017
-
$1.71 M(-92.3%)
$33.82 M(-7.5%)
Jun 2017
-
$22.23 M(+2847.6%)
$36.55 M(+68.5%)
Mar 2017
-
$754.00 K(-91.7%)
$21.68 M(-62.2%)
Dec 2016
$57.41 M(+256.2%)
$9.14 M(+106.1%)
$57.41 M(-3.7%)
Sep 2016
-
$4.43 M(-39.8%)
$59.59 M(+6.2%)
Jun 2016
-
$7.36 M(-79.8%)
$56.12 M(+12.6%)
Mar 2016
-
$36.48 M(+222.1%)
$49.86 M(+209.4%)
Dec 2015
$16.12 M(-73.2%)
$11.32 M(+1074.7%)
$16.12 M(-28.6%)
Sep 2015
-
$964.00 K(-12.4%)
$22.58 M(-63.1%)
Jun 2015
-
$1.10 M(-59.7%)
$61.15 M(-0.4%)
Mar 2015
-
$2.73 M(-84.7%)
$61.39 M(+2.2%)
Dec 2014
$60.08 M(+73.2%)
$17.79 M(-55.0%)
$60.08 M(-20.1%)
Sep 2014
-
$39.53 M(+2843.7%)
$75.17 M(+108.8%)
Jun 2014
-
$1.34 M(-4.8%)
$36.00 M(+3.0%)
Mar 2014
-
$1.41 M(-95.7%)
$34.96 M(+0.8%)
Dec 2013
$34.68 M(>+9900.0%)
$32.88 M(+8984.0%)
$34.68 M(+1833.0%)
Sep 2013
-
$362.00 K(+18.3%)
$1.79 M(+25.3%)
Jun 2013
-
$306.00 K(-72.8%)
$1.43 M(+27.2%)
Mar 2013
-
$1.13 M(+276.6%)
$1.13 M(+213.6%)
Dec 2010
$319.00 K(+298.8%)
-
-
Jun 2010
-
$299.00 K(+1395.0%)
$359.00 K(+348.8%)
Mar 2010
-
$20.00 K(0.0%)
$80.00 K(0.0%)
Dec 2009
$80.00 K(-99.3%)
$20.00 K(0.0%)
$80.00 K(-96.9%)
Sep 2009
-
$20.00 K(0.0%)
$2.61 M(-49.7%)
Jun 2009
-
$20.00 K(0.0%)
$5.19 M(-35.6%)
Mar 2009
-
$20.00 K(-99.2%)
$8.06 M(-29.5%)
Dec 2008
$11.43 M(+8901.6%)
$2.55 M(-2.0%)
$11.43 M(+27.7%)
Sep 2008
-
$2.60 M(-10.0%)
$8.95 M(+40.5%)
Jun 2008
-
$2.89 M(-14.8%)
$6.37 M(+82.0%)
Mar 2008
-
$3.39 M(+4965.7%)
$3.50 M(+2656.7%)
DateAnnualQuarterlyTTM
Dec 2007
$127.00 K(+58.8%)
$67.00 K(+235.0%)
$127.00 K(+58.8%)
Sep 2007
-
$20.00 K(0.0%)
$80.00 K(0.0%)
Jun 2007
-
$20.00 K(0.0%)
$80.00 K(0.0%)
Mar 2007
-
$20.00 K(0.0%)
$80.00 K(0.0%)
Dec 2006
$80.00 K(-99.5%)
$20.00 K(0.0%)
$80.00 K(-93.6%)
Sep 2006
-
$20.00 K(0.0%)
$1.25 M(-50.4%)
Jun 2006
-
$20.00 K(0.0%)
$2.52 M(-74.7%)
Mar 2006
-
$20.00 K(-98.3%)
$9.97 M(-38.0%)
Dec 2005
$16.09 M(-45.6%)
$1.19 M(-7.6%)
$16.09 M(-30.1%)
Sep 2005
-
$1.29 M(-82.7%)
$23.03 M(-24.3%)
Jun 2005
-
$7.47 M(+21.6%)
$30.41 M(-2.7%)
Mar 2005
-
$6.14 M(-24.5%)
$31.24 M(+5.6%)
Dec 2004
$29.59 M(+19.5%)
$8.13 M(-6.2%)
$29.59 M(+3.2%)
Sep 2004
-
$8.67 M(+4.4%)
$28.68 M(+8.0%)
Jun 2004
-
$8.30 M(+84.6%)
$26.55 M(+8.9%)
Mar 2004
-
$4.50 M(-37.7%)
$24.38 M(-1.6%)
Dec 2003
$24.77 M(+46.6%)
$7.22 M(+10.4%)
$24.77 M(-2.9%)
Sep 2003
-
$6.54 M(+6.7%)
$25.50 M(+9.1%)
Jun 2003
-
$6.13 M(+25.6%)
$23.38 M(+16.3%)
Mar 2003
-
$4.88 M(-38.7%)
$20.09 M(+18.9%)
Dec 2002
$16.90 M(+170.9%)
$7.96 M(+80.3%)
$16.90 M(+48.8%)
Sep 2002
-
$4.41 M(+55.1%)
$11.36 M(+42.9%)
Jun 2002
-
$2.85 M(+69.0%)
$7.95 M(+13.7%)
Mar 2002
-
$1.68 M(-30.4%)
$6.99 M(+12.1%)
Dec 2001
$6.24 M(+1142.2%)
$2.42 M(+140.7%)
$6.24 M(+44.3%)
Sep 2001
-
$1.00 M(-46.8%)
$4.32 M(+30.3%)
Jun 2001
-
$1.89 M(+102.9%)
$3.32 M(+131.7%)
Mar 2001
-
$929.30 K(+85.1%)
$1.43 M(+185.1%)
Dec 2000
$502.00 K(+402.0%)
$502.00 K(>+9900.0%)
$502.00 K(+402.0%)
Sep 2000
-
$0.00(0.0%)
$100.00 K(0.0%)
Jun 2000
-
$0.00(0.0%)
$100.00 K(0.0%)
Mar 2000
-
$0.00(-100.0%)
$100.00 K(0.0%)
Dec 1999
$100.00 K(-99.2%)
$100.00 K(>+9900.0%)
$100.00 K(-97.0%)
Sep 1999
-
$0.00(0.0%)
$3.30 M(-43.1%)
Jun 1999
-
$0.00(0.0%)
$5.80 M(-41.4%)
Mar 1999
-
$0.00(-100.0%)
$9.90 M(-25.0%)
Dec 1998
$13.20 M(+11.9%)
$3.30 M(+32.0%)
$13.20 M(+3.1%)
Sep 1998
-
$2.50 M(-39.0%)
$12.80 M(-7.9%)
Jun 1998
-
$4.10 M(+24.2%)
$13.90 M(+6.1%)
Mar 1998
-
$3.30 M(+13.8%)
$13.10 M(+11.0%)
Dec 1997
$11.80 M(+29.7%)
$2.90 M(-19.4%)
$11.80 M(+32.6%)
Sep 1997
-
$3.60 M(+9.1%)
$8.90 M(+67.9%)
Jun 1997
-
$3.30 M(+65.0%)
$5.30 M(+165.0%)
Mar 1997
-
$2.00 M
$2.00 M
Dec 1996
$9.10 M
-
-

FAQ

  • What is CTI BioPharma annual revenue?
  • What is the all time high annual revenue for CTI BioPharma?
  • What is CTI BioPharma quarterly revenue?
  • What is the all time high quarterly revenue for CTI BioPharma?
  • What is CTI BioPharma quarterly revenue year-on-year change?
  • What is CTI BioPharma TTM revenue?
  • What is the all time high TTM revenue for CTI BioPharma?
  • What is CTI BioPharma TTM revenue year-on-year change?

What is CTI BioPharma annual revenue?

The current annual revenue of CTIC is $53.95 M

What is the all time high annual revenue for CTI BioPharma?

CTI BioPharma all-time high annual revenue is $60.08 M

What is CTI BioPharma quarterly revenue?

The current quarterly revenue of CTIC is $24.12 M

What is the all time high quarterly revenue for CTI BioPharma?

CTI BioPharma all-time high quarterly revenue is $39.53 M

What is CTI BioPharma quarterly revenue year-on-year change?

Over the past year, CTIC quarterly revenue has changed by +$21.82 M (+950.81%)

What is CTI BioPharma TTM revenue?

The current TTM revenue of CTIC is $75.77 M

What is the all time high TTM revenue for CTI BioPharma?

CTI BioPharma all-time high TTM revenue is $75.77 M

What is CTI BioPharma TTM revenue year-on-year change?

Over the past year, CTIC TTM revenue has changed by +$73.47 M (+3201.48%)